Authors:
Christiansen, JS
Bengtsson, BA
Thorner, MO
Hintz, R
Sonksen, PH
Cohen, P
Clemmons, D
Strasburger, CJ
Carlsson, L
Tanaka, T
Robinson, I
Jorgensen, JO
Johannson, G
Clayton, PE
Cowell, CT
Malozowski, SN
Hankinson, S
Yee, D
Baxter, R
Swerdlow, A
Rosenfeld, R
Fradkin, JE
Nishi, Y
Monson, JP
van den Berghe, G
Carroll, PV
Takala, J
van der Lely, AJ
Pollak, MN
LeRoith, D
Tachibana, K
Kappelgaard, AM
Langbakke, I
Lippe, B
Wilton, P
Stein, P
Salazar, DE
Maneatis, T
Blethen, SL
Cutler, GB
Blum, WF
Svanberg, E
Gertner, JM
Shimatsu, A
Takahashi, H
Citation: Js. Christiansen et al., Critical evaluation of the safety of recombinant human growth hormone administration: Statement from the growth hormone research society, J CLIN END, 86(5), 2001, pp. 1868-1870
Citation: Pv. Carroll et al., Growth hormone replacement in adults with growth hormone deficiency: Assessment of current knowledge, TRENDS ENDO, 11(6), 2000, pp. 231-238
Citation: Nc. Jackson et al., Effects of glutamine supplementation, GH, and IGF-I on glutamine metabolism in critically ill patients, AM J P-ENDO, 278(2), 2000, pp. E226-E233
Authors:
Carroll, PV
Christ, ER
Umpleby, AM
Gowrie, I
Jackson, N
Bowes, SB
Hovorka, R
Croos, P
Sonksen, PH
Russell-Jones, DL
Citation: Pv. Carroll et al., IGF-I treatment in adults with type 1 diabetes - Effects on glucose and protein metabolism in the fasting state and during a hyperinsulinemic-euglycemic amino acid clamp, DIABETES, 49(5), 2000, pp. 789-796
Citation: Pv. Carroll, Protein metabolism and the use of growth hormone and insulin-like growth factor-I in the critically ill patient, GROWTH H I, 9(6), 1999, pp. 400-413
Citation: Nc. Jackson et al., The metabolic consequences of critical illness: acute effects on glutamineand protein metabolism, AM J P-ENDO, 39(1), 1999, pp. E163-E170
Authors:
Carroll, PV
Umpleby, M
Alexander, EL
Egel, VA
Callison, KV
Sonksen, PH
Russell-Jones, DL
Citation: Pv. Carroll et al., Recombinant human insulin-like growth factor-I (rhIGF-I) therapy in adultswith type 1 diabetes mellitus: effects on IGFs, IGF-binding proteins, glucose levels and insulin treatment, CLIN ENDOCR, 49(6), 1998, pp. 739-746